Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
QuintilesIMS
AstraZeneca
Citi
Mallinckrodt
Chinese Patent Office
Accenture
Baxter
Teva
Cantor Fitzgerald

Generated: August 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065058

« Back to Dashboard
NDA 065058 describes CEFACLOR, which is a drug marketed by Watson Labs Inc, Ceph Intl, Facta Farma, Dava Pharms Inc, Yung Shin Pharm, Teva, Hikma, Ranbaxy, World Gen, and Ivax Sub Teva Pharms, and is included in twenty-nine NDAs. It is available from eleven suppliers. Additional details are available on the CEFACLOR profile page.

The generic ingredient in CEFACLOR is cefaclor. There are thirteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the cefaclor profile page.

Summary for NDA: 065058

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 065058

Ingredient-typeCephalosporins

Suppliers and Packaging for NDA: 065058

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CEFACLOR
cefaclor
TABLET, EXTENDED RELEASE;ORAL 065058 ANDA Teva Pharmaceuticals USA Inc 0093-1087 0093-1087-01 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0093-1087-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 375MG BASE
Approval Date:Sep 4, 2002TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 500MG BASE
Approval Date:Sep 4, 2002TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Citi
McKinsey
Medtronic
Mallinckrodt
Moodys
Julphar
UBS
Novartis
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot